Lv41
470 积分 2025-04-11 加入
Current insights and barriers in FGFR-mediated signaling in lung cancer
1小时前
已完结
Disposition and Absolute Bioavailability of Orally Administered Orforglipron in Healthy Participants
12天前
已完结
The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
13天前
已完结
APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer
13天前
已完结
Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance
27天前
已完结
Development of a Novel Assay for Direct Assessment of Selective Amylin Receptor Activation Reveals Novel Differences in Behavior of Selective and Nonselective Peptide Agonists
1个月前
已完结
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
1个月前
已完结
Abstract P141: Preclinical characterization of LOX-24350, a highly potent and isoform-selective FGFR3 inhibitor
1个月前
已关闭
Enhancing siRNA efficacy in vivo with extended nucleic acid backbones
1个月前
已完结
Comprehensive analysis of sequence-specific stability of siRNA
1个月前
已完结
皖公网安备34019202002308
